Treatment patterns for metastatic colorectal cancer in Spain

por Aranda, E., Polo, E., Camps, C., Carrato, A., Díaz-Rubio, E., Guillem, V., López, R., Antón, A.
Publicado 2020

Risk assessment model for first-cycle chemotherapy-induced neutropenia in patients with solid tumours

por LÓPEZ-POUSA, A, RIFÀ, J, CASAS DE TEJERINA, A, GONZÁLEZ-LARRIBA, JL, IGLESIAS, C, GASQUET, JA, CARRATO, A
Publicado 2010

Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus

por Carrato, A., Cerezo, L., Feliu, J., Macarulla, T., Martín-Pérez, E., Vera, R., Álvarez, J., Botella-Carretero, J. I.
Publicado 2021

A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs

por Carrato, A., Falcone, A., Ducreux, M., Valle, J. W., Parnaby, A., Djazouli, K., Alnwick-Allu, K., Hutchings, A., Palaska, C., Parthenaki, I.
Publicado 2015

Seom guidelines for the treatment of gastric cancer 2015

por Martin-Richard, M., Custodio, A., García-Girón, C., Grávalos, C., Gomez, C., Jimenez-Fonseca, P., Manzano, J. L., Pericay, C., Rivera, F., Carrato, A.
Publicado 2015

Erratum to: SEOM guidelines for the treatment of gastric cancer 2015

por Martin-Richard, M., Custodio, A., García-Girón, C., Grávalos, C., Gomez, C., Jimenez-Fonseca, P., Manzano, J. L., Pericay, C., Rivera, F., Carrato, A.
Publicado 2016

SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)

por Gómez-España, Mª A., Montes, A. F., Garcia-Carbonero, R., Mercadé, T. M., Maurel, J., Martín, A. M., Pazo-Cid, R., Vera, R., Carrato, A., Feliu, J.
Publicado 2021

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy

por Martinez-Balibrea, E, Abad, A, Martínez-Cardús, A, Ginés, A, Valladares, M, Navarro, M, Aranda, E, Marcuello, E, Benavides, M, Massutí, B, Carrato, A, Layos, L, Manzano, J L, Moreno, V
Publicado 2010

Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

por López de Maturana, E., Picornell, A., Masson-Lecomte, A., Kogevinas, M., Márquez, M., Carrato, A., Tardón, A., Lloreta, J., García-Closas, M., Silverman, D., Rothman, N., Chanock, S., Real, F. X., Goddard, M. E., Malats, N.
Publicado 2016

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

por Hecht, J.R., Raman, S.S., Chan, A., Kalinsky, K., Baurain, J.-F., Jimenez, M.M., Garcia, M.M., Berger, M.D., Lauer, U.M., Khattak, A., Carrato, A., Zhang, Y., Liu, K., Cha, E., Keegan, A., Bhatta, S., Strassburg, C.P., Roohullah, A.
Publicado 2023

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumo...

por Carrato, A., Benavides, M., Massutí, B., Ferreiro-Monteagudo, R., García Alfonso, P., Falcó, E., Reboredo, M., Cano, T., Gallego, J., Viéitez, J. M., Layos, L., Salud, A., Polo, E., Dotor, E., Durán-Ogalla, G., Rodriguez-Garrote, M., Calvo, A., Grande, E., Aranda, E.
Publicado 2019

LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk

por Tajuddin, S M, Amaral, A F S, Fernández, A F, Chanock, S, Silverman, D T, Tardón, A, Carrato, A, García-Closas, M, Jackson, B P, Toraño, E G, Márquez, M, Urdinguio, R G, García-Closas, R, Rothman, N, Kogevinas, M, Real, F X, Fraga, M F, Malats, N
Publicado 2014